Summary & Overview
CPT 92083: Extended Visual Field Examination with Interpretation
CPT code 92083 is a critical procedure in ophthalmology, representing an extended visual field examination with interpretation and report. This code is widely used to assess and monitor patients with complex visual field abnormalities, including those with glaucoma, optic nerve disorders, and intracranial pathologies that may impact vision. The procedure is typically performed in an ophthalmology office and is essential for comprehensive evaluation of visual function.
Major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, provide coverage for this service. The publication offers insights into payer policies, clinical indications, and billing practices associated with 92083. Readers will find information on relevant modifiers, associated taxonomies, and ICD-10 diagnoses that support medical necessity for this procedure. Additionally, the article highlights related CPT codes, such as 92082 and 92250, to provide context for visual field and retinal imaging services.
This summary equips healthcare professionals, billing specialists, and policy analysts with a comprehensive understanding of the clinical and administrative aspects of 92083. Key benchmarks, policy updates, and clinical context are presented to support accurate coding and reimbursement for extended visual field examinations.
CPT Code Overview
CPT code 92083 represents a visual field examination, performed unilaterally or bilaterally, with interpretation and report. This is an extended examination used in ophthalmology to assess the patient's visual field in greater detail. The service is typically provided in an ophthalmology office setting, such as place of service 11. This procedure is essential for evaluating complex visual field abnormalities and monitoring conditions that affect vision.
Clinical & Coding Specifications
Clinical Context
A patient presents to an ophthalmology office with symptoms such as decreased peripheral vision, visual disturbances, or is undergoing routine monitoring for a known diagnosis of glaucoma or optic nerve disorder. The ophthalmologist orders a visual field examination to assess the extent and pattern of visual field loss. The procedure involves an extended visual field test, typically using automated perimetry, performed on one or both eyes. The results are interpreted by the physician, and a formal report is generated to guide diagnosis, management, or monitoring of conditions such as glaucoma, optic nerve disorders, or intracranial pathology affecting vision.
Coding Specifications
-
Modifiers:
- Modifier
26: Used to indicate the professional component, when the physician interprets the visual field test and provides a report. - Modifier
TC: Used to indicate the technical component, when the facility provides the equipment and technical staff for the test.
- Modifier
-
Provider Taxonomies:
207W00000X: Represents the specialty of Ophthalmology.
| Modifier Code | Description |
|---|---|
| 26 | Professional component |
| TC | Technical component |
| Taxonomy Code | Specialty |
|---|---|
| 207W00000X | Ophthalmology |
Related Diagnoses
-
Glaucoma codes (e.g., H40.*): Glaucoma diagnosis supporting medical necessity- Visual field testing is essential for diagnosing and monitoring glaucoma, as it helps detect and track progressive visual field loss.
-
Optic nerve/neurologic visual pathway disorders: Disorders of optic nerve or visual pathway- Extended visual field examination is used to evaluate patients with optic nerve damage or neurological conditions affecting the visual pathway.
-
Brain mass or intracranial hemorrhage codes: Intracranial pathology potentially affecting visual fields- Visual field testing assists in identifying visual deficits caused by intracranial masses or hemorrhages that impact the visual pathways.
Related CPT Codes
-
92082: Visual field examination, unilateral or bilateral, with interpretation and report; intermediate examination- Used for less extensive visual field testing. May be performed when a full extended examination is not clinically indicated. It is an alternative to
92083for intermediate complexity cases.
- Used for less extensive visual field testing. May be performed when a full extended examination is not clinically indicated. It is an alternative to
-
92250: Fundus photography with interpretation and report- Used to document the appearance of the retina and optic nerve. Often performed in conjunction with
92083to provide a comprehensive assessment of ocular health, especially in patients with glaucoma or optic nerve disorders.
- Used to document the appearance of the retina and optic nerve. Often performed in conjunction with
| CPT Code | Description | Relationship to 92083 |
|---|---|---|
| 92082 | Visual field exam, intermediate | Alternative for less extensive testing |
| 92250 | Fundus photography with interpretation and report | Commonly used together for assessment |
National Reimbursement Benchmarks
National mean rates for CPT code 92083 show that Blue Cross Blue Shield, Aetna, Cigna, UnitedHealth Group, and BUCA all reimburse at higher levels than Medicare. The average commercial mean rate (BUCA) is $58.79, while Medicare's mean rate is $44.29, reflecting a significant gap between commercial and government payer reimbursement.
Rate dispersion varies across payers. Cigna exhibits the widest spread, with a difference of $36.33 between its 75th and 25th percentiles, indicating greater variability in payment rates. In contrast, Aetna has the tightest range at $25.67, suggesting more consistent reimbursement levels. Other payers fall between these extremes, with Medicare's range at $33.00 and BUCA at $26.01.
The table and chart below present a detailed breakdown of national benchmarks for each payer, including mean rates and percentile values.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.